Major Ingredients

Each vial contains Voriconazole USP 200mg sterile lyophilized powder.

Major Functionality

It is indicated for the treatment of adults and pediatric patients 2 years of age and older with: Invasive aspergillosis, Candidemia in non-neutropenics and other deep tissue Candida infections, Esophageal candidiasis, Serious fungal infections caused by Scedosporium apiospermum and Fusarium species including Fusarium solani, in patients intolerant of, or refractory to, other therapy.

Manufacture Information

Drug International Limited was incorporated under the Registrar of Joint Stock Companies in 1974 as a Private Limited Company. The company commenced formulation and production in 1983 and emerged as a pioneer in Bangladesh for adding a state of the art oral solid dosage plant. Since inception, Drug International Limited's primary objective has been to meet guidelines provided by major global regulatory bodies such as the World Health Organization Good Manufacturing Practices (WHO cGMP) guidelines.